Article

AI-based antibody discovery platform identifies novel, diverse and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strains

2023-08-22

Abstract excerpt

<h4>ABSTRACT</h4> A critical aspect of a successful pandemic response is expedient antibody discovery, manufacturing and deployment of effective lifesaving treatments to patients around the world. However, typical drug discovery and development is a lengthy multi-step process that must align drug efficacy with multiple developability criteria and can take years to complete. In this context, artificial intelligenc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 819fa5b0-6b90-544e-9ad5-f8dca04715f6
DOI: 10.1101/2023.08.21.554197

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

AI-based antibody discovery platform identifies novel, diverse and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strainsDOI 10.1101/2023.08.21.554197Read

Potent SARS-CoV-2 neutralizing antibodies selected from a human antibody library constructed decades agoSemantic proximity Read

Massively Multiplexed Affinity Characterization of Therapeutic Antibodies Against SARS-CoV-2 VariantsSemantic proximity Read

Rapid <i>in silico</i> design of antibodies targeting SARS-CoV-2 using machine learning and supercomputingSemantic proximity Read

Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizersSemantic proximity Read

High-throughput ML-guided design of diverse single-domain antibodies against SARS-CoV-2Semantic proximity Read

Broad Epitope Coverage of Therapeutic Multi-Antibody Combinations Targeting SARS-CoV-2 Boosts In Vivo Protection and Neutralization Potency to Corner an Immune-Evading VirusSemantic proximity Read

Antibody drugs targeting SARS-CoV-2: Time for a rethink?Semantic proximity Read

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infectionSemantic proximity Read

Optimizing a Human Monoclonal Antibody for Better Neutralization of SARS-CoV-2Semantic proximity Read

Exploring epitope and functional diversity of anti-SARS-CoV2 antibodies using AI-based methodsSemantic proximity Read

Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domainSemantic proximity Read

In silico evaluation of ten monoclonal antibodies neutralization power of SARS-CoV-2 variants EG.5 and BA.2.86Semantic proximity Read